Faculty Profile

Mark Harrison

BSc(Hons), MSc, PhD
Associate Professor

Other Affiliations

Scientist, Centre for Health Evaluation and Outcome Sciences (CHÉOS); Providence Health Care Research Institute; Professorship in Sustainable Health Care

Contact Information

Primary Phone Number (604) 827-0687
Email Address mark.harrison@ubc.ca
Office 4625, Pharmaceutical Sciences Building

Selected Publications

Harrison M, Spooner L, Bansback N, Milbers K, Koehn C, Shojania K, Finckh A, Hudson M. Preventing rheumatoid arthritis: Preferences for and predicted uptake of preventive treatments among high risk individuals. PLoS One. 2019 Apr 25;14(4):e0216075. doi: 10.1371/journal.pone.0216075. PMID: 31022252; PMCID: PMC6483264.

Munro, S., Spooner, L., Milbers, K. et al. Perspectives of patients, first-degree relatives and rheumatologists on preventive treatments for rheumatoid arthritis: a qualitative analysis. BMC Rheumatol 2, 18 (2018). https://doi.org/10.1186/s41927-018-0026-7

Harrison M, Milbers K, Hudson M, et al. Do patients and health care providers have discordant preferences about which aspects of treatments matter most? Evidence from a systematic review of discrete choice experiments. BMJ Open 2017;7:e014719. doi: 10.1136/bmjopen-2016-014719

Kolhatkar A, Cheng L, Chan FK, Harrison M, Law MR. The impact of medication reviews by community pharmacists. J Am Pharm Assoc (2003). 2016 Sep-Oct;56(5):513-520.e1. doi: 10.1016/j.japh.2016.05.002. PMID: 27594104.

Meacock R, Sutton M, Kristensen SR, Harrison M. Using Survival Analysis to Improve Estimates of Life Year Gains in Policy Evaluations. Medical Decision Making. 2017;37(4):415-426. doi:10.1177/0272989X16654444

Harrison M, Marra CA, Bansback N. Preferences for 'New' Treatments Diminish in the Face of Ambiguity. Health Econ. 2017 Jun;26(6):743-752. doi: 10.1002/hec.3353. Epub 2016 May 12. PMID: 27174417.

Harrison MJ, Dusheiko M, Sutton M, Gravelle H, Doran T, Roland M. Effect of a national primary care pay for performance scheme on emergency hospital admissions for ambulatory care sensitive conditions: controlled longitudinal study. BMJ. 2014 Nov 11;349:g6423. doi: 10.1136/bmj.g6423. PMID: 25389120; PMCID: PMC4228282.

Awards

Michael Smith Foundation for Health Research Scholar Award (2017)

The Arthritis Society Young Investigator Salary Award (2016)

Health Economist, Health Technology Appraisal Committee, Health Technology Review, British Columbia Ministry of Health (2017)

Association of Faculties of Pharmacy of Canada New Investigator Research Award (2016)

University of British Columbia Certificate on Curriculum & Pedagogy in Higher Education: Faculty 3.Scholarship of Teaching and Learning (SoTL) Leadership Program (2016)

Faculty Instructional Workshop Certificate, Centre for Teaching, Learning and Technology,University of British Columbia (2015)

"OMERACT Fellow." Harrison MJ. OMERACT QALY Group (2008)

Grants

"Perspectives on the implementation of a multidisciplinary conference fee code for community-based patients with rheumatic disease in BC (RHEUM-NURSE)" Harrison MJ (PI). $66,665. Canadian Initiative for Outcomes in Rheumatology cAre (CIORA). 2019.

"Incentivizing the delivery of sustainable care of chronic diseases in Canada: case studies in musculoskeletal disease." Harrison MJ (PI). $450,000. Michael Smith Foundation for Health Research, Scholar Award. 2017.

"A population-based analysis of multi-disciplinary rheumatology nursing care for people with complex rheumatic diseases." Harrison MJ (PI). $271,397. CIHR Project Grant. 2016.

"Incentivizing the delivery of sustainable health care in Canada; applications in musculoskeletal disease." Harrison MJ (PI). $180,000. The Arthritis Society. 2016.

"Preventing rheumatoid arthritis (Pre-RA): perspectives of people at risk and of rheumatologists on selected interventions." Harrison MJ (Co-PI), Dr. M. Hudson (Co-PI). $82,933. Canadian Initiative for Outcomes in Rheumatology cAre (CIORA). 2015.

Presentations

"Preventive treatment for rheumatoid arthritis: are we looking in the right direction?" Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford UK. January, 12 2018.

"What are the impacts of billing codes for nurse management of complex rheumatic diseases in British Columbia? Let's talk about it..." Knowledge Exchange, British Columbia Ministry of Health, Victoria BC. July 27, 2017.

"Has the UK quality and outcomes framework improved outcomes for people with chronic diseases? Lessons for other health care systems." Knowledge Exchange Forum. School of Public Health, University of Rwanda. October 19, 2016.

"Were emergency admissions for ambulatory care sensitive conditions reduced in a UK pay for performance scheme?" Centre for Clinical Epidemiology and Evaluation (C2E2) Rounds, Vancouver Coastal Health Research Institute, Vancouver, BC. June 22, 2015.

"Sustainable healthcare – looking for the answers within the system." Rx&D Innovation and Healthcare Sustainability Policy Forum. Vancouver, BC. January 26, 2015.

About

Dr. Mark Harrison joined the UBC Faculty of Pharmaceutical Sciences in 2014. Dr. Harrison leads a health economics program within the Collaboration for Outcomes Research and Evaluation (CORE) group with an interest in patient-physician decision-making, understanding the role of preferences in treatment decisions, and evaluating the impact of policy interventions on patient and health care system outcomes. Dr. Harrison is the health economist on the British Columbia Ministry of Health's Health Technology Assessment Committee, and a member of the Canadian Rheumatology Association's Human Resources Committee.

Dr. Harrison holds a first class honours degree in business and management sciences from the University of Bradford, UK, master's degree in epidemiology from the University of Edinburgh, and PhD from the University of Manchester. He began his research career with the Arthritis Research UK Epidemiology Unit at the University of Manchester in 2002, focusing on the variation in service provision and treatment outcomes in people with rheumatoid arthritis, drug safety and the evaluation of treatment strategies. Following the completion of his PhD, he worked at the Manchester Centre for Health Economics at the University of Manchester on a range of projects with academic, governmental, and industry partners. He also served as an adviser for the National Institute of Health Research (NIHR) Research Design Service. Dr. Harrison has a strong publication record with over 60 publications.

Dr. Harrison's main research interests are in evaluating treatment outcomes in chronic diseases and understanding patient preferences in the role of treatment decision-making; he has published numerous works on the epidemiology, cost-effectiveness of treatments, and patient preferences and health-related quality of life, of those with rheumatic diseases using administrative and routinely collected data and surveys of patients. Mark has also contributed to improving health care systems and health care delivery in Canada and the UK, through his work addressing the impact of policy interventions including medication reviews, integrated and multidisciplinary care on patient and health care system outcomes, and whether better quality management of chronic conditions in community-based primary health care, through mechanisms like incentive schemes, reduces emergency hospital admissions. More recently, Mark has been exploring the role of patient preferences and market research techniques, including the presentation and role of risk and uncertainty in patient health care decision making, to support patient-oriented research design.

Dr. Harrison will continue to focus on chronic diseases and multimorbidity and combine these themes to improve the efficiency of the health care system in delivering timely, high quality of care, consistent with informed patient preferences, to improve patient outcomes and contain costs.

Dr. Harrison welcomes enquiries from prospective graduate students with an interest in areas including health economics, health outcomes, health policy, and decision analysis.